These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

974 related items for PubMed ID: 22390866

  • 1. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L, Sólyom E, Lombay B, Almási A, Vámosi I.
    Orv Hetil; 2012 Mar 18; 153(11):418-24. PubMed ID: 22390866
    [Abstract] [Full Text] [Related]

  • 2. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P, Suphasit R, Mahachoklertwattana P.
    Gynecol Endocrinol; 2011 Aug 18; 27(8):524-8. PubMed ID: 21501002
    [Abstract] [Full Text] [Related]

  • 3. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
    Chen SK, Fan X, Tang Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May 18; 11(5):374-6. PubMed ID: 19470261
    [Abstract] [Full Text] [Related]

  • 4. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
    Pasquino AM, Pucarelli I, Accardo F, Demiraj V, Segni M, Di Nardo R.
    J Clin Endocrinol Metab; 2008 Jan 18; 93(1):190-5. PubMed ID: 17940112
    [Abstract] [Full Text] [Related]

  • 5. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF, McNeill E, Young D, Donaldson MD.
    Clin Endocrinol (Oxf); 2004 Nov 18; 61(5):626-34. PubMed ID: 15521967
    [Abstract] [Full Text] [Related]

  • 6. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F.
    J Clin Endocrinol Metab; 1999 Feb 18; 84(2):449-52. PubMed ID: 10022399
    [Abstract] [Full Text] [Related]

  • 7. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J, Reynaud R, Czernichow P.
    J Pediatr; 2000 Dec 18; 137(6):819-25. PubMed ID: 11113839
    [Abstract] [Full Text] [Related]

  • 8. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
    Gillis D, Karavani G, Hirsch HJ, Strich D.
    J Pediatr; 2013 Aug 18; 163(2):532-6. PubMed ID: 23485026
    [Abstract] [Full Text] [Related]

  • 9. Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height.
    Chiocca E, Dati E, Baroncelli GI, Mora S, Parrini D, Erba P, Bertelloni S.
    Neuroendocrinology; 2009 Aug 18; 89(4):441-7. PubMed ID: 19176945
    [Abstract] [Full Text] [Related]

  • 10. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height.
    Lazar L, Kauli R, Pertzelan A, Phillip M.
    J Clin Endocrinol Metab; 2002 May 18; 87(5):2090-4. PubMed ID: 11994346
    [Abstract] [Full Text] [Related]

  • 11. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function.
    Heger S, Partsch CJ, Sippell WG.
    J Clin Endocrinol Metab; 1999 Dec 18; 84(12):4583-90. PubMed ID: 10599723
    [Abstract] [Full Text] [Related]

  • 12. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
    Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G.
    Eur J Pediatr; 1998 May 18; 157(5):363-7. PubMed ID: 9625331
    [Abstract] [Full Text] [Related]

  • 13. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
    Yuan JN, Liang L, Cai XD, Li Z, Bai M, Gu CP.
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov 18; 13(11):896-9. PubMed ID: 22099200
    [Abstract] [Full Text] [Related]

  • 14. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation.
    Antoniazzi F, Zamboni G, Bertoldo F, Lauriola S, Mengarda F, Pietrobelli A, Tatò L.
    J Clin Endocrinol Metab; 2003 Mar 18; 88(3):1096-101. PubMed ID: 12629090
    [Abstract] [Full Text] [Related]

  • 15. Consensus statement on the use of gonadotropin-releasing hormone analogs in children.
    Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, ESPE-LWPES GnRH Analogs Consensus Conference Group, Antoniazzi F, Berenbaum S, Bourguignon JP, Chrousos GP, Coste J, Deal S, de Vries L, Foster C, Heger S, Holland J, Jahnukainen K, Juul A, Kaplowitz P, Lahlou N, Lee MM, Lee P, Merke DP, Neely EK, Oostdijk W, Phillip M, Rosenfield RL, Shulman D, Styne D, Tauber M, Wit JM.
    Pediatrics; 2009 Apr 18; 123(4):e752-62. PubMed ID: 19332438
    [Abstract] [Full Text] [Related]

  • 16. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM, Harris DA, Egli CA, Conte FA, Kaplan SL, Rivier J, Vale W, Grumbach MM.
    J Clin Endocrinol Metab; 1985 Jul 18; 61(1):142-51. PubMed ID: 3923027
    [Abstract] [Full Text] [Related]

  • 17. Does GnRH analog improve the final height in Thai girls with idiopathic central precocious puberty?
    Wacharasindhu S, Srivuthana S, Aroonparkmongkol S, Trinavarat P.
    J Med Assoc Thai; 2001 Jun 18; 84 Suppl 1():S51-6. PubMed ID: 11529380
    [Abstract] [Full Text] [Related]

  • 18. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty.
    van Gool SA, Kamp GA, Visser-van Balen H, Mul D, Waelkens JJ, Jansen M, Verhoeven-Wind L, Delemarre-van de Waal HA, de Muinck Keizer-Schrama SM, Leusink G, Roos JC, Wit JM.
    J Clin Endocrinol Metab; 2007 Apr 18; 92(4):1402-8. PubMed ID: 17284626
    [Abstract] [Full Text] [Related]

  • 19. Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature.
    Kapteijns-van Kordelaar S, Noordam K, Otten B, van den Bergh J.
    Eur J Pediatr; 2003 Nov 18; 162(11):776-80. PubMed ID: 13680381
    [Abstract] [Full Text] [Related]

  • 20. Predictive factors for the effect of gonadotrophin releasing hormone analogue therapy on the height of girls with idiopathic central precocious puberty.
    Brauner R, Malandry F, Rappaport R.
    Eur J Pediatr; 1992 Oct 18; 151(10):728-30. PubMed ID: 1425790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.